10450 Science Center Drive
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

• ABOUT DEPOBUPIVACAINE
• Benefits
• Administration
• Marketing Opportunity
• Status

Pacira has successfully completed Phase I and II studies in several surgical pain models with multiple routes of administration, including infiltration, epidural, and peripheral nerve block. The phase III clinical program is studying DepoBupivacaine administered by deep tissue infiltration for postsurgical pain.

• QUICK FACTS
• Targeted to reduce or prevent moderate to severe postsurgical pain
• A single injection designed to provide pain relief for 72 hours
• Potential to minimize the use of opioids
• May lead to improved recovery, and shorter hospitalizations

• Contact Us
• Careers
• Legal

© 2008 Pacira Pharmaceuticals